MEDIA

Title	Date
The Board of Directors Approved the 2022 Q2 Consolidated Financial Statements	2022-08-12
Announce the new appointment of the general manager	2022-08-12
Announcement of the BOD resolved to release of non-compete restrictions for the manager	2022-08-12
To announce the change of General Manager	2022-07-11
To announce the change of the spokesperson	2022-07-11
Announced BOD's resolution that the related matters of ex-rights and ex-dividend	2022-06-30
Announce on behalf of major subsidiary Cotton Field Organic Co., Ltd.,the record date for dividend distribution.	2022-06-10
Microbio Co.,LTD. receives a R.O.C. patent on the new drug MS-20 (CHEMO YOUNG).	2022-06-01
To announce 2022 Shareholders' Meeting majoy resolutions.	2022-05-27
Approved the removal of restrictions imposed against the director for involving in competing businesses by the Annual General Shareholders' meeting.	2022-05-27
Announcement of the first quarter of Year 2022 consolidated financial reports were approved by the BOD	2022-05-11
Announce to modify the use of cash capital increase of 2007.	2022-05-11
Subsidiary received the unblinding data from CRO, engaged by Oneness, regarding US Phase II clinical trial of FB825 to treat moderate-to-severe atopic dermatitis.	2022-05-02
Microbio Ranked among Top 5% in the 8th Corporate Governance Evaluation	2022-04-29
Microbio Co., Ltd. receives a Brazil patent on the new drug MS-20 (CHEMO YOUNG).	2022-04-15
Announcement of Year 2021 consolidated financial reports were approved by the BOD	2022-03-15
Announcement of dividends distribution approved by the BOD	2022-03-15
Announcement of the resolution of the BOD to issue new shares through capitalization of capital surplus	2022-03-15
Board's resolution to convene the 2022 Annual General Meeting (Method of convening the meeting: hybrid shareholders' meeting)	2022-03-15
Announcement of the resolution of the BOD to convene the 2022 annual shareholders' meeting	2022-02-25

1 2 3 4 5 6